Latest News

Circassia's Allergy Therapy Begins Phase II Clinical Trial in Asthma Patients

21 April 2009

Circassia Completes Patient Recruitment For Phase II Clinical Trial Of ToleroMune Allergy Treatment

07 January 2009

Circassia Acquires North American and Japanese rights to Dopexamine

08 October 2008

Circassia Initiates Further Phase II Clinical Study Of ToleroMune® Anti-Allergy Technology

02 October 2008

Circassia Achieves Successful Phase II Clinical Results With ToleroMune® Anti-Allergy Technology

10 September 2008

More recent news articles

Previous news articles

Did you know?

The average bed could be home to up to 1.5 million house dust mites